BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 14575832)

  • 1. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma.
    Hyun Kim T; Choi J; Park SY; Lee SH; Lee KC; Yang DS; Shin KH; Cho KH; Lim HS; Kim JY
    Cancer; 2005 Sep; 104(6):1304-11. PubMed ID: 16078262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer.
    Suzuki O; Yoshioka Y; Isohashi F; Morimoto M; Kotsuma T; Kawaguchi Y; Konishi K; Nakamura S; Shiomi H; Inoue T
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1329-34. PubMed ID: 18439763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis.
    Roeske JC; Mundt AJ; Halpern H; Sweeney P; Sutton H; Powers C; Rotmensch J; Waggoner S; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):351-8. PubMed ID: 9069307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis.
    Clark BG; Souhami L; Roman TN; Evans MD; Pla C
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1243-50. PubMed ID: 8175412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prediction of late rectal complications following the treatment of uterine cervical cancer by high-dose-rate brachytherapy.
    Chen SW; Liang JA; Yang SN; Liu RT; Lin FJ
    Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):955-61. PubMed ID: 10863065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between in vivo dosimetry and barium contrast technique for prediction of rectal complications in high-dose-rate intracavitary radiotherapy in cervix cancer patients.
    Huh SJ; Lim DH; Ahn YC; Lee JE; Kang MK; Shin SS; Shin KH; Kim B; Park W; Han Y
    Strahlenther Onkol; 2003 Mar; 179(3):191-6. PubMed ID: 12627263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
    Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
    J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of reference points by dosimetric analyses for late complications after uniform external radiotherapy and high-dose-rate brachytherapy for cervical cancer.
    Chen SW; Liang JA; Yeh LS; Yang SN; Shiau AC; Lin FJ
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):663-71. PubMed ID: 15380604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of correlation between rectal complications and rectal dose following high dose rate intracavitary radiotherapy in patients with uterine cervix cancer: in vivo dosimetric analysis.
    Shin KH; Huh SJ; Chie EK; Choi DR; Lim DH; Kim MK; Lee KC; Kim DY; Ahn YC
    Radiat Med; 1999; 17(4):289-93. PubMed ID: 10510902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed-dose-rate vs. high-dose-rate intracavitary radiotherapy for locally advanced carcinoma of cervix: A prospective randomized study.
    Kumar P; Sharma DN; Kumar S; Gandhi AK; Rath GK; Julka PK
    Brachytherapy; 2016; 15(3):327-332. PubMed ID: 26996595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?
    Kim HJ; Kim S; Ha SW; Wu HG
    Tumori; 2008; 94(3):327-32. PubMed ID: 18705399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy.
    Koom WS; Sohn DK; Kim JY; Kim JW; Shin KH; Yoon SM; Kim DY; Yoon M; Shin D; Park SY; Cho KH
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1446-54. PubMed ID: 17482766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
    Ferrigno R; dos Santos Novaes PE; Pellizzon AC; Maia MA; Fogarolli RC; Gentil AC; Salvajoli JV
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1123-35. PubMed ID: 11483321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal dose and source strength of the high-dose-rate iridium-192 both affect late rectal bleeding after intracavitary radiation therapy for uterine cervical carcinoma.
    Isohashi F; Yoshioka Y; Koizumi M; Suzuki O; Konishi K; Sumida I; Takahashi Y; Ogata T; Kotsuma T; Inoue T
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):758-64. PubMed ID: 19836150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.